1. Home >
  2. M&A >
  3. Stake Purchase >
  4. United States >
  5. Massachusetts >
  6. Gedeon Richter Invests In Granata Bio

Investment Summary

Gedeon Richter Invests In Granata Bio

On May 13, 2025, Gedeon Richter invested in life science company Granata Bio

Investment Highlights
  • This is Gedeon Richter’s 1st transaction in the Life Science sector.
  • This is Gedeon Richter’s 1st transaction in the United States.
  • This is Gedeon Richter’s 1st transaction in Massachusetts.

Investment Summary
Date 2025-05-13
Target Granata Bio
Sector Life Science
Investor(s) Gedeon Richter
Deal Type Stake Purchase

Target

Granata Bio

Duxbury, Massachusetts, United States
Granata Bio is a U.S.-based biopharmaceutical company dedicated to advancing innovation in women's health and infertility. Granata Bio's pipeline includes a range of fertility therapies, with collaborations spanning multiple drug classes to address unmet needs in reproductive medicine. Granata Bio was formed in 2018 and is based in Duxbury, Massachusetts.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Investor(S) 1

Investor

Gedeon Richter

Budapest, Hungary
Category Company
Founded 1901
Sector Life Science
Employees10,943
Revenue 857.5B HUF (2024)
DESCRIPTION

Gedeon Richter is a multinational company that is vertically integrated and involves pharmaceutical manufacturing, research and development, sales, and marketing. Gedeon Richter was founded in 1901 and is based in Budapest, Hungary.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Stake Purchase M&A Deals 1 of 1
State: Massachusetts M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2025 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal